Insider Transactions in Q2 2024 at Viking Therapeutics, Inc. (VKTX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2024
|
Greg Zante Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
66,756
-7.45%
|
$4,939,944
$74.87 P/Share
|
|
May 03
2024
|
Greg Zante Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,249
+6.51%
|
$136,996
$4.78 P/Share
|
|
May 01
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
281,425
-10.65%
|
$21,951,150
$78.38 P/Share
|
|
May 01
2024
|
Marianna Mancini Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
281,425
+9.65%
|
$1,688,550
$6.33 P/Share
|